Suicide Clinical Trial - Effectiveness of the Suicidal Crisis Intervention

Status Recruiting

Clinical Trial Summary

The main objective of this project is to be able to offer a new, specific evidence-based short-term treatment method, the Suicidal Crisis Intervention (SCI), to reduce suicidality. In addition, this study aims to investigate the influence of SCI on other important aspects of suicidality (secondary goal) such as hopelessness, defeat, entrapment, and interpersonal needs.

Clinical Trial Description

Research has extensively shown that a previous suicide attempt or a history of suicide attempts are important predictors of suicide death. It is therefore important to provide people with appropriate care after a suicide attempt to limit this risk. Although this risk factor (previous attempts) is known, the number of interventions developed for this risk group is limited. Based on these findings, a short-term treatment trajectory was developed for people after a suicide attempt or a suicidal crisis in Flanders, called the Suicidal Crisis Intervention (SCI). This was inspired by the ASSIP treatment trajectory and the safety plan was also given a significant place within the treatment. In addition, the importance of relatives and social support is emphasized by involving relatives in this treatment. Throughout this treatment, further (treatment) goals are drawn up, in order to generate hope for improvement and to facilitate continuity of care. More information about the concrete content of SCI will follow later in this protocol. A pilot study is currently being conducted to assess the feasibility of this treatment, as well as the experience of patients, relatives and care providers. Based on this, the SCI will be further updated for this effectiveness study. There are currently no specific evidence-based short-term treatment methods in Flanders for people after a suicidal crisis or suicide attempt. The primary research question is therefore: 'Is the Suicidal Crisis Intervention (SCI) in Flanders an effective short-term treatment method for people after a suicidal crisis or suicide attempt?'. The main objective of this project is to be able to offer a new, specific short-term treatment method that has been scientifically proven to reduce suicidality. In addition, we want to investigate the influence of SCI on other important aspects of suicidality (secondary goal) such as hopelessness, defeat, entrapment, and interpersonal needs. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05638204
Study type	Interventional
Source	University Hospital, Ghent
Contact	Eva De Jaegere, Msc
Phone	+32 (0)9 332.07.75
Email	eva.dejaegere@ugent.be
Status	Recruiting
Phase	N/A
Start date	July 11, 2023
Completion date	January 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04127292` - Impact of Clinician Virtual Human Interaction Training in Emotional Self-Awareness on Patients Suicidal Ideation and Suicide Crisis Syndrome	N/A
Recruiting	`NCT06079853` - Nurse Suicide: Physiologic Sleep Health Promotion Trial	N/A
Recruiting	`NCT05423483` - Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents	Phase 2
Completed	`NCT03272048` - Identifying Effective Approaches to Counseling on Firearm Safety	N/A
Completed	`NCT05514587` - Meaning of Life Questionnaire (MLQ) in Patients Admitted to the Crisis Centre (MSVCAC)
Enrolling by invitation	`NCT05639426` - Preventing Youth Violence Through Building Equitable Communities	N/A
Completed	`NCT03703128` - Suicide in People Aged 45-60: A Case-control Psychological Autopsy Study
Completed	`NCT03646903` - Reducing Help-Seeking Stigma in Young Adults at Elevated Suicide Risk	N/A
Not yet recruiting	`NCT06349915` - A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents	N/A
Not yet recruiting	`NCT05558332` - Youth Nominated Support Team	N/A
Completed	`NCT02718248` - Ottawa Suicide Prevention in Men Pilot Study	N/A
Completed	`NCT02094898` - Ketamine for Depression and Suicide Risk	Phase 2
Completed	`NCT01360736` - A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL)	N/A
Completed	`NCT01594138` - Linguistic Characteristics of Suicidal Patients in the Emergency Department	N/A
Completed	`NCT02228044` - Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment	N/A
Completed	`NCT00604097` - Preventing Youth Suicide in Primary Care: A Family Model	Phase 3
Completed	`NCT00387855` - An Evaluation of the SOS (Suicide Prevention) Program	N/A
Recruiting	`NCT03519802` - Evaluation of Cognitive Function in a Suicidal Crisis
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting	`NCT03030924` - Wearable Suicidal Early Warning System for Adolescents

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effectiveness of the Suicidal Crisis Intervention (SCI) — RCT SCI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms